2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Jean-Pascal Machiels, MD, head of the Department of Medical Oncology, Cliniques Universitaires Sain-Luc, discusses challenges still facing the field of head and neck cancer and ongoing trials with a goal to improve patient outcomes.
Jean-Pascal Machiels, MD, head of the Department of Medical Oncology, Cliniques Universitaires Sain-Luc, discusses challenges still facing the field of head and neck cancer and ongoing trials with a goal to improve patient outcomes.
There are still many challenges facing the field of head and neck cancer, explains Machiels. Head and neck cancer is mostly induced by tobacco and alcohol use, which adds many comorbidities for these patients.
There are ongoing trials with avelumab (Bavencio) combined with chemoradiation, which can possibly help improve the outcomes for these patients.
Related Content: